Lifeloc Technologies, Inc (LCTC) — SEC Filings
Lifeloc Technologies, Inc (LCTC) — 21 SEC filings. Latest: 10-Q (Nov 12, 2025). Includes 11 8-K, 6 10-Q, 2 DEF 14A.
View Lifeloc Technologies, Inc on SEC EDGAR
Overview
Lifeloc Technologies, Inc (LCTC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 12, 2025: Lifeloc Technologies, Inc. (LCTC) reported a net loss of $949,764 for the nine months ended September 30, 2025, a significant increase from the $740,121 net loss in the prior-year period. This 28.3% deterioration in net loss occurred despite a modest 1.9% increase in total revenues, which reached $6
Sentiment Summary
Across 21 filings, the sentiment breakdown is: 2 bearish, 19 neutral. The dominant filing sentiment for Lifeloc Technologies, Inc is neutral.
Filing Type Overview
Lifeloc Technologies, Inc (LCTC) has filed 6 10-Q, 11 8-K, 2 DEF 14A, 2 10-K with the SEC between Apr 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (21)
Risk Profile
Risk Assessment: Of LCTC's 20 recent filings, 2 were flagged as high-risk, 6 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $6,753,858 |
| Net Income | -$949,764 |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $685,097 |
| Operating Margin | -53.8% |
| Total Assets | N/A |
| Total Debt | N/A |
Industry Context
Lifeloc Technologies operates in the breathalyzer and drug detection device market. This sector is influenced by regulatory mandates for workplace safety, law enforcement requirements, and increasing awareness of substance abuse. Competition can arise from both established players and new entrants offering advanced or more cost-effective solutions.
Top Tags
financial-reporting (5) · 10-Q (4) · financials (4) · 8-K (3) · quarterly-report (3) · Financial Performance (2) · material-definitive-agreement (2) · disclosure (2) · Laboratory Instruments (2) · corporate-governance (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $949,764 | Increased 28.3% for the nine months ended September 30, 2025, compared to $740,121 in 2024. |
| Total Revenues | $6,753,858 | Increased 1.9% for the nine months ended September 30, 2025, from $6,628,099 in 2024. |
| Cash and Cash Equivalents | $685,097 | Decreased from $1,243,746 at December 31, 2024, indicating significant cash burn. |
| Net Cash Used in Operating Activities | $578,437 | For the nine months ended September 30, 2025, highlighting operational cash outflow. |
| Interest Expense | $87,753 | Increased significantly from $30,226 in the prior year, contributing to higher losses. |
| Research and Development Expenses | $1,551,689 | Decreased from $1,738,982 in 2024, a 10.8% reduction. |
| Retained Earnings (Accumulated Deficit) | $(309,901) | Shifted from a positive balance of $639,863 at December 31, 2024, to a deficit. |
| Common Stock Shares Outstanding | 2,752,616 | As of November 10, 2025, up from 2,664,116 at December 31, 2024. |
| Total Revenue (Q2 2025) | $1.47M | Decreased by 24.9% from $1.96M in Q2 2024 |
| Product Sales (Q2 2025) | $1.39M | Fell by 25.5% from $1.865M in Q2 2024 |
| Total Revenue (YTD 2025) | $3.00M | Decreased by 19.3% from $3.72M in YTD 2024 |
| Quarterly Revenue Decrease | 24.9% | Percentage decline in total revenue for Q2 2025 compared to Q2 2024 |
| Year-to-Date Revenue Decrease | 19.3% | Percentage decline in total revenue for the six months ended June 30, 2025, compared to the prior year |
| Reporting Period End Date | 2025-03-31 | Indicates the end of the fiscal quarter for which financial information is reported. |
| Filing Date | 2025-05-15 | The date the 10-Q report was officially submitted to the SEC. |
Frequently Asked Questions
What are the latest SEC filings for Lifeloc Technologies, Inc (LCTC)?
Lifeloc Technologies, Inc has 21 recent SEC filings from Apr 2024 to Nov 2025, including 11 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LCTC filings?
Across 21 filings, the sentiment breakdown is: 2 bearish, 19 neutral. The dominant sentiment is neutral.
Where can I find Lifeloc Technologies, Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Lifeloc Technologies, Inc (LCTC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Lifeloc Technologies, Inc?
Key financial highlights from Lifeloc Technologies, Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for LCTC?
The investment thesis for LCTC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Lifeloc Technologies, Inc?
Executive information for Lifeloc Technologies, Inc is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Lifeloc Technologies, Inc stock?
Of LCTC's 20 assessed filings, 2 were flagged high-risk, 6 medium-risk, and 12 low-risk.
What are recent predictions and forward guidance from Lifeloc Technologies, Inc?
Forward guidance and predictions for Lifeloc Technologies, Inc are extracted from SEC filings as they are enriched.